We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAN:EURONEXT PARISSanofi SA Analysis

Data as of 2026-05-19 - not real-time

$11.78

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Banco Santander posted a record Q1 2026 profit of €3.6 bn, up 12% YoY, with revenue rising 6% and costs down 1%, driven by a significant disposal gain. Technical indicators show a bullish alignment as the 20‑day SMA (12.00) sits above the 50‑day (11.72) and 200‑day (11.07) averages, while the RSI at 46 suggests the stock is not yet overbought. However, the MACD is bearish, with the line below its signal, and volume trends are decreasing, hinting at potential short‑term weakness. The price currently trades at €11.78, just above the identified support of €11.51 and below resistance at €12.52, offering a modest upside of about 1.2% per the upside/downside metric. Valuation metrics are attractive: a trailing PE of 11.4 versus the industry average of 16.5 and a price‑to‑book of 1.45, complemented by a 2.35% dividend yield and a modest 25% payout ratio, indicating sustainability. Fundamentally, revenue growth of 4.6% and a profit margin of 34% reinforce the earnings momentum, though operating cash flow remains negative, a point to monitor.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with limited upside
  • Bearish MACD divergence despite bullish SMA alignment
  • Decreasing volume indicating waning short‑term momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Record earnings beat and strong profit growth
  • Undervalued relative to peers (low PE, attractive PB)
  • Sustainable dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistent dividend policy and healthy yield
  • Solid capital position and improving earnings trajectory
  • Long‑term exposure to diversified banking franchise across Europe

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin34.10%
P/E Ratio11.4
ROE12.89%
ROA0.78%
P/B Ratio1.4
Op. Cash Flow$-15418000384
Industry P/E16.5

Technical Analysis

TrendBullish
RSI46.2
Support$11.51
Resistance$12.52
MA 20$12.00
MA 50$11.72
MA 200$11.07
MACDBearish
VolumeDecreasing
Fear & Greed Index89.16

Valuation

Target Price$11.92
Upside/Downside1.22%
GradeUndervalued
TypeBlend
Dividend Yield2.35%

Risk Assessment

Beta1.61
Volatility36.41%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.